Critical care and cirrhosis: Outcome and benefit

Current Opinion in Critical Care

Volumn 17, Issue 5, 2011, Pages 533-537

  Wendon, Julia ^a   Bernal, William ^a   Willars, Chris ^a   Auzinger, Georg ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

alcoholic hepatitis; cirrhosis; hepatic encephalopathy; renal failure; variceal bleed

Indexed keywords

ADRENAL DISEASE; ALCOHOL LIVER DISEASE; BLEEDING; CARDIOPULMONARY INSUFFICIENCY; ELECTIVE SURGERY; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; REVIEW; SCORING SYSTEM; SPONTANEOUS PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME; VARICOSIS;

CRITICAL CARE; HUMANS; LIVER CIRRHOSIS; PORTASYSTEMIC SHUNT, SURGICAL; TREATMENT OUTCOME;

EID: 80052764164     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32834ab06f     Document Type: Review

References (42)

1. Cholongitas E, Papatheodoridis GV, Vangeli M, et al. Systematic review: the model for end-stage liver disease-should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005; 22:1079-1089. (Pubitemid 41779515)
2. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45:797-805. (Pubitemid 46450631)
3. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470. (Pubitemid 32119037)
4. Brown MR, Jones G, Nash KL, et al. Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates. World J Gastroenterol 2010; 16:5317-5323.
5. Chau TN, Chan YW, Patch D, et al. Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut 1998; 43:267-271. (Pubitemid 28348333)
6. Lo GH, Chen WC, Wang HM, et al. Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices. Gut 2009; 58:1275-1280.
7. Combier E, Levacher S, Letoumelin P, et al. Cost-effectiveness analysis of the terlipressin-glycerin trinitrate combination in the prehospital management of acute gastro-intestinal haemorrhage in cirrhotic patients. Intensive Care Med 1999; 25:364-370. (Pubitemid 29192468)
8. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40:793-801. (Pubitemid 39288111)
9. Bambha K, Kim WR, Pedersen R, et al. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 2008; 57:814-820. (Pubitemid 351716977)
10. Procaccini NJ, Al-Osaimi AM, Northup P, et al. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 2009; 70: 881-887.
11. Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362:2370-2379.
12. Arroyo V, Fernandez J. Pathophysiological basis of albumin use in cirrhosis. Ann Hepatol 2011; 10 (Suppl 1):S6-14.
13. Arroyo V, Fernandez J, Gines P. Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 2008; 28:81-95. (Pubitemid 351326535)
14. Gluud LL, Christensen K, Christensen E, Krag A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 2010; 51:576-584.
15. Martin-Llahi M, Pepin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008; 134:1352-1359. (Pubitemid 351626950)
16. Krag A, Moller S, Henriksen JH, et al. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology 2007; 46:1863-1871.
17. Martin-Llahi M, Guevara M, Torre A, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011; 140:488-496.e4.
18. Fang JT, Tsai MH, Tian YC, et al. Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure. Nephrol Dial Transplant 2008; 23:1961-1969.
19. Jenq CC, Tsai MH, Tian YC, et al. RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 2007; 33:1921-1930.
20. Wehler M, Kokoska J, Reulbach U, et al. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 2001; 34:255-261. (Pubitemid 32702337)
21. Cholongitas E, Calvaruso V, Senzolo M, et al. RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol Hepatol 2009; 24:1639-1647.
22. Swanson KL, Wiesner RH, Nyberg SL, et al. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant 2008; 8:2445-2453.
23. Cholongitas E, Senzolo M, Patch D, et al. Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol 2009; 21:744-750.
24. Henriksen JH, Moller S. Cardiac and systemic haemodynamic complications of liver cirrhosis. Scand Cardiovasc J 2009; 43:218-225.
25. Kochar R, Nevah Rubin MI, Fallon MB. Pulmonary complications of cirrhosis. Curr Gastroenterol Rep 2011; 13:34-39.
26. Tsai MH, Peng YS, Chen YC, et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006; 43:673-681.
27. Arabi YM, Aljumah A, Dabbagh O, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 2010; 182:1971-1977.
28. Shawcross DL, Sharifi Y, Canavan JB, et al. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 2011; 54:640-649.
29. Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2010; 51:1062-1069.
30. Hassanein TI, Tofteng F, Brown RS Jr, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007; 46:1853-1862.
31. Cordoba J, Lopez-Hellin J, Planas M, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 2004; 41:38-43. (Pubitemid 39005150)
32. Mathurin P, O'Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011; 60:255-260.
33. Forrest EH, Evans CD, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54:1174-1179. (Pubitemid 41025916)
34. Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45:1348-1354. (Pubitemid 46918318)
35. Louvet A, Wartel F, Castel H, et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009; 137:541-548.
36. Sandahl TD, Jepsen P, Ott P, Vilstrup H. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol 2011. [Epub ahead of print]
37. Neeff H, Mariaskin D, Spangenberg HC, et al. Perioperative mortality after nonhepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000 s using Child and MELD scores. J Gastrointest Surg 2011; 15:1-11.
38. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007; 132:1261-1269. (Pubitemid 46627576)
39. Warrillow SJ. Predictions and outcomes for the critically ill patient with cirrhosis: is it time to settle on the SOFA and let jaundiced views on outcome MELD away? Crit Care Med 2010; 38:2259-2260.
40. Cholongitas E, Betrosian A, Senzolo M, et al. Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission. J Gastroenterol Hepatol 2008; 23:1223-1227.
41. Gunsar F, Raimondo ML, Jones S, et al. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006; 24:563-572. (Pubitemid 44127837)
42. Das V, Boelle PY, Galbois A, et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med 2010; 38:2108-2116.